SACM - United Kingdom
Permanent URI for this collectionhttps://drepo.sdl.edu.sa/handle/20.500.14154/9667
Browse
2 results
Search Results
Item Restricted Review of effects of Covid-19 on insurance(University Of Strathclyde, 2023-12-17) Alqahtani, Ali; Foondun, MohammudAlthough there is a growing volume of research on the consequences of the COVID-19 pandemic, an in-depth study that explicitly looks at these implications from an actuarial viewpoint is still needed. Such studies can advance our knowledge of how flexible the insurance sector is during major global crises. The COVID-19 virus is a devastating illness that has spread fast over the world, impacting people in a variety of ways (Khan et al., 2020). Apart from having a significant impact on people's health and rising death rates, it also had a significant impact on the economy owing to lockdowns and the shutdown of enterprises globally (Mofijur et al., 2021). Change is nothing new for the insurance sector. It is fair to predict that the repercussions of the 2020 worldwide pandemic will affect the sector, given the numerous historical occurrences and unanticipated losses that prompted these changes. Businesses are struggling as a result of governmental regulations that prevent some from operating at full capacity while forcing others to shut down altogether, resulting in revenue losses (Robinson, 2020). Most of the time, individuals look to the insurance sector and governments throughout the world as their sources of hope in order to be saved from complete devastation. However, the pandemic has overburdened several governments and financially crippled certain insurance companies due to the rapid growth in cases of infection which appears higher than the recovery of affected persons (Babuna et al., 2020). The COVID-19 epidemic has had profound and complicated impacts on the insurance sector (Thorburn et al., 2020).9 0Item Restricted Assessing compliance within B. Braun in relation to the industry codes(Saudi Digital Library, 2023-09) Alqahtani, Ali; Perera, TerrenceThis exploratory study aimed to understand the nature of regulatory compliance within B. Braun focuses on the perceptions and experiences of its marketing and sales staff and highlights areas for improvement. B. Braun's multifaceted healthcare offerings navigate a complex regulatory landscape, made more challenging by the diverse regulatory codes they must adhere to. This research addresses a gap in the literature, emphasising the alignment of corporate culture with compliance in the dynamic healthcare industry, especially in the UK. Through a combination of descriptive and thematic analyses, this study utilised qualitative methods, capturing insights from marketing and sales staff about their experiences with regulatory codes and the company's code of conduct. Findings indicated commendable awareness and alignment with B. Braun's code of conduct among employees. However, particular areas, notably targeted marketing, warrant strategic refinement. There is a clear emphasis on the need for consistent and tailored training, given the changing regulatory landscape. Moreover, B. Braun's dedication to transparency and adherence sets a standard in the industry. The study emphasises the importance of a responsive strategy, including regulatory adaptability, technology adoption, partnerships, and ethics. While the company's adherence to ethical standards is noteworthy, there's room for improvement, particularly in training for both teams' compliance. This research offers a unique perspective, clarifying the UK healthcare regulatory dynamics and providing practical insights. For stakeholders, it underscores the advantages of a robust compliance culture, highlighting the need for proactive measures in areas like training. Addressing these would benefit B. Braun's internal operations in light of the relevant codes and reinforce its market position, reflecting broader industry challenges.11 0